Cargando…

Epigenetic mechanisms in Alzheimer’s disease [Corrigendum]

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2014
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337144/ https://www.ncbi.nlm.nih.gov/pubmed/32673378 http://dx.doi.org/10.2147/DNND.S72446

Ejemplares similares

Corrigendum to: Epigenetic dysregulation in meningiomas
Publicado: (2023)

Speech and orofacial apraxias in Alzheimer's disease – CORRIGENDUM
por: Cera, Maysa Luchesi, et al.
Publicado: (2013)

Profile of gantenerumab and its potential in the treatment of Alzheimer’s disease [Corrigendum]
Publicado: (2014)

Corrigendum to “Slower Dynamics and Aged Mitochondria in Sporadic Alzheimer's Disease”
por: Martín-Maestro, Patricia, et al.
Publicado: (2021)

Corrigendum to “Epigenetic and Neural Circuitry Landscape of Psychotherapeutic Interventions”
por: Miller, Christopher W. T.
Publicado: (2017)

Corrigendum: Involvement of insulin receptor substrates in cognitive impairment and Alzheimer’s disease
Publicado: (2019)

Corrigendum: Comparing progression biomarkers in clinical trials of early Alzheimer’s disease
Publicado: (2021)

The Epigenetic Mechanisms of Nanotopography-Guided Osteogenic Differentiation of Mesenchymal Stem Cells via High-Throughput Transcriptome Sequencing [Corrigendum]
Publicado: (2023)

Literature Overview of the Relation Between Psoriasis and Alzheimer [Corrigendum]
Publicado: (2023)

Corrigendum to “MUTYH Actively Contributes to Microglial Activation and Impaired Neurogenesis in the Pathogenesis of Alzheimer's Disease”
por: Mizuno, Yuri, et al.
Publicado: (2023)

Effects of galantamine in a 2-year, randomized, placebo-controlled study in Alzheimer’s disease [Corrigendum]
Publicado: (2014)

Serum miR-128 Serves as a Potential Diagnostic Biomarker for Alzheimer’s Disease [Corrigendum]
Publicado: (2021)

Corrigendum to “Maintenance of mitochondrial homeostasis for Alzheimer's disease: Strategies and challenges” [Redox Biol. 63 (2023) 102734]
por: Han, Ying, et al.
Publicado: (2023)

Corrigendum to: ATRI EDC: a novel cloud-native remote data capture system for large multicenter Alzheimer’s disease and Alzheimer’s disease-related dementias clinical trials
por: Jimenez-Maggiora, Gustavo A, et al.
Publicado: (2022)

CORRIGENDUM: Correction of funding statement in ACKNOWLEDGEMENTS section: Epigenetic inactivation of RUNX3 in colorectal cancer
por: Shin, Eung Jin, et al.
Publicado: (2018)

Corrigendum to: Adolescent Epigenetic Profiles and Environmental Exposures from Early Life through Peri-Adolescence
Publicado: (2021)

Corrigendum to “Contribution of Neurons and Glial Cells to Complement-Mediated Synapse Removal during Development, Aging and in Alzheimer's Disease”
por: Luchena, Celia, et al.
Publicado: (2019)

Corrigendum to “Caffeine's Vascular Mechanisms of Action”
por: Echeverri, Darío, et al.
Publicado: (2019)

Corrigendum: Body weight and high‐fat diet are associated with epigenetic aging in female members of the BXD murine family
Publicado: (2021)

Antimetastatic Effect of Epigenetic Drugs, Hydralazine and Valproic Acid, in Ras-Transformed NIH 3T3 Cells [Corrigendum]
Publicado: (2022)

PPARγ Agonist-Loaded PLGA-PEG Nanocarriers as a Potential Treatment for Alzheimer’s Disease: In vitro and in vivo Studies [Corrigendum]
Publicado: (2023)

Corrigendum to: Rotor mechanism and its mapping in atrial fibrillation
Publicado: (2023)

Corrigendum to “Alzheimer's Disease Dementia as the Diagnosis Best Supported by the Cerebrospinal Fluid Biomarkers: Difference in Cut-Off Levels from Thai Experience”
por: Senanarong, Vorapun, et al.
Publicado: (2017)

Corrigendum to: Capillary Inward-Rectifying K(+) Channels Crippled in a Mouse Model of Alzheimer’s Disease: Phosphatidylinositol 4,5-Bisphosphate to the Rescue!
Publicado: (2021)

Corrigendum: Anodal transcranial direct current stimulation alleviates cognitive impairment in an APP/PS1 model of Alzheimer’s disease in the preclinical stage
Publicado: (2023)

[Corrigendum] Neuroprotective effect of emodin against Alzheimer’s disease via Nrf2 signaling in U251 cells and APP/PS1 mice
por: Li, Zhiping, et al.
Publicado: (2023)

Effects of Creative Expression Therapy for Older Adults with Mild Cognitive Impairment at Risk of Alzheimer’s Disease: A Randomized Controlled Clinical Trial [Corrigendum]
Publicado: (2023)

Diversity and evolution of drug resistance mechanisms in Mycobacterium tuberculosis [Corrigendum]
Publicado: (2017)

Corrigendum to “Dietary Lipids in Health and Disease”
por: Amin, Kamal A., et al.
Publicado: (2020)

Corrigendum to “Helicobacter pylori infection contributes to the expression of Alzheimer's disease-associated risk factors and neuroinflammation” [Heliyon 9(9) (September 2023) e19607]
por: Noori, Maryam, et al.
Publicado: (2023)

Corrigendum to “Pediatric Traumatic Brain Injury and Autism: Elucidating Shared Mechanisms”
por: Singh, Rahul, et al.
Publicado: (2017)

Corrigendum to: Neural mechanisms of predicting individual preferences based on group membership
por: Vijayakumar, Suhas, et al.
Publicado: (2021)

Corrigendum to ‘clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome’
por: Scholl, Suzy, et al.
Publicado: (2020)

Corrigendum to “Plant-Derived Antioxidants in Disease Prevention”
por: Szymanska, Renata, et al.
Publicado: (2017)

Parkinson’s disease managing reversible neurodegeneration [Corrigendum]
Publicado: (2016)

Corrigendum to: One Health for Neglected Tropical Diseases
por: Laing, Gabrielle, et al.
Publicado: (2021)

Corrigendum
Publicado: (2014)

Corrigendum
Publicado: (2014)

Corrigendum
Publicado: (2014)

Corrigendum
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_mu5ronkc8u4a14tr3bi9hgic2b